Barings Corporate Investors (MCI) Competitors $20.30 -0.18 (-0.85%) Closing price 08/14/2025 03:54 PM EasternExtended Trading$20.67 +0.38 (+1.87%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MCI vs. BCAT, OXLC, CET, GSBD, MFIC, NMFC, PFLT, BBDC, AWF, and BCSFShould you be buying Barings Corporate Investors stock or one of its competitors? The main competitors of Barings Corporate Investors include BlackRock Capital Allocation Term Trust (BCAT), Oxford Lane Capital (OXLC), Central Securities (CET), Goldman Sachs BDC (GSBD), MidCap Financial Investment (MFIC), New Mountain Finance (NMFC), PennantPark Floating Rate Capital (PFLT), BARINGS BDC (BBDC), AllianceBernstein Global High Income Fund (AWF), and Bain Capital Specialty Finance (BCSF). These companies are all part of the "financial services" industry. Barings Corporate Investors vs. Its Competitors BlackRock Capital Allocation Term Trust Oxford Lane Capital Central Securities Goldman Sachs BDC MidCap Financial Investment New Mountain Finance PennantPark Floating Rate Capital BARINGS BDC AllianceBernstein Global High Income Fund Bain Capital Specialty Finance Barings Corporate Investors (NYSE:MCI) and BlackRock Capital Allocation Term Trust (NYSE:BCAT) are both small-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Does the media refer more to MCI or BCAT? In the previous week, Barings Corporate Investors had 3 more articles in the media than BlackRock Capital Allocation Term Trust. MarketBeat recorded 5 mentions for Barings Corporate Investors and 2 mentions for BlackRock Capital Allocation Term Trust. BlackRock Capital Allocation Term Trust's average media sentiment score of 1.47 beat Barings Corporate Investors' score of 0.33 indicating that BlackRock Capital Allocation Term Trust is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Barings Corporate Investors 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BlackRock Capital Allocation Term Trust 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, MCI or BCAT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBarings Corporate InvestorsN/AN/AN/AN/AN/ABlackRock Capital Allocation Term Trust$197.67M8.25N/AN/AN/A Do insiders & institutionals hold more shares of MCI or BCAT? 36.1% of BlackRock Capital Allocation Term Trust shares are owned by institutional investors. 1.1% of Barings Corporate Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is MCI or BCAT a better dividend stock? Barings Corporate Investors pays an annual dividend of $1.60 per share and has a dividend yield of 7.9%. BlackRock Capital Allocation Term Trust pays an annual dividend of $3.40 per share and has a dividend yield of 22.4%. Is MCI or BCAT more profitable? Company Net Margins Return on Equity Return on Assets Barings Corporate InvestorsN/A N/A N/A BlackRock Capital Allocation Term Trust N/A N/A N/A Which has more volatility & risk, MCI or BCAT? Barings Corporate Investors has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, BlackRock Capital Allocation Term Trust has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. SummaryBlackRock Capital Allocation Term Trust beats Barings Corporate Investors on 5 of the 7 factors compared between the two stocks. Get Barings Corporate Investors News Delivered to You Automatically Sign up to receive the latest news and ratings for MCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCI vs. The Competition Export to ExcelMetricBarings Corporate InvestorsFIN IndustryFinance SectorNYSE ExchangeMarket Cap$415.51M$14.09B$12.42B$21.04BDividend Yield7.82%5.71%5.54%3.57%P/E RatioN/A27.1519.6928.08Price / SalesN/A7.1525.7857.05Price / CashN/A16.6121.7623.95Price / BookN/A2.642.295.26Net IncomeN/A$572.25M$1.00B$994.11M7 Day Performance-0.10%1.58%1.75%2.09%1 Month Performance-4.66%3.14%2.42%2.35%1 Year Performance11.94%13.86%542.40%13.36% Barings Corporate Investors Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCIBarings Corporate InvestorsN/A$20.30-0.9%N/A+12.9%$415.51MN/A0.00N/ANews CoverageDividend AnnouncementShort Interest ↓BCATBlackRock Capital Allocation Term TrustN/A$14.93+0.8%N/A-4.6%$1.60B$197.67M0.00147,000Positive NewsShort Interest ↓OXLCOxford Lane Capital2.0263 of 5 stars$3.45-0.6%N/A-34.4%$1.56B$57.31M4.16601CETCentral SecuritiesN/A$48.35+0.7%N/A+15.2%$1.40B$296.20M0.006News CoveragePositive NewsGSBDGoldman Sachs BDC1.194 of 5 stars$11.11+0.6%$12.00+8.0%-18.0%$1.29B$434.37M24.69N/ADividend AnnouncementMFICMidCap Financial Investment1.5899 of 5 stars$12.35flat$13.50+9.3%-2.3%$1.15B$113.46M9.96N/AEarnings ReportNMFCNew Mountain Finance2.3282 of 5 stars$10.33-0.9%$10.67+3.3%-14.0%$1.12B$371.67M10.33N/APositive NewsPFLTPennantPark Floating Rate Capital3.0167 of 5 stars$10.44+0.3%$10.96+5.0%-6.3%$1.03B$84.09M7.45658News CoverageAnalyst ForecastShort Interest ↓BBDCBARINGS BDC2.8041 of 5 stars$9.18-0.1%$9.67+5.4%-2.4%$967.65M$286.17M9.7626Dividend AnnouncementAWFAllianceBernstein Global High Income FundN/A$11.17+0.4%N/A+3.1%$959.74MN/A0.00N/APositive NewsBCSFBain Capital Specialty Finance2.3395 of 5 stars$14.67-0.4%$16.50+12.5%-3.7%$954.86M$292.65M8.431,000 Related Companies and Tools Related Companies BlackRock Capital Allocation Term Trust Alternatives Oxford Lane Capital Alternatives Central Securities Alternatives Goldman Sachs BDC Alternatives MidCap Financial Investment Alternatives New Mountain Finance Alternatives PennantPark Floating Rate Capital Alternatives BARINGS BDC Alternatives AllianceBernstein Global High Income Fund Alternatives Bain Capital Specialty Finance Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MCI) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Barings Corporate Investors Please log in to your account or sign up in order to add this asset to your watchlist. Share Barings Corporate Investors With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access